# SOX30

## Overview
SOX30 is a gene that encodes the SRY-box transcription factor 30, a member of the SOX family of transcription factors. These proteins are characterized by the presence of a High Mobility Group (HMG) domain, which facilitates DNA binding and transcriptional regulation. The SOX30 protein plays a crucial role in the regulation of gene expression during spermatogenesis, particularly in the later stages of meiosis and spermiogenesis, and is essential for male fertility (Feng2017SOX30; Bai2018Sox30). Beyond its role in reproductive biology, SOX30 also functions as a tumor suppressor in various cancers, including lung adenocarcinoma, where it modulates key signaling pathways and promotes apoptosis (Han2014SOX30; Hao2018SOX30). Alterations in SOX30 expression and methylation have been implicated in several diseases, making it a potential biomarker for prognosis and therapeutic targeting in conditions such as non-small cell lung cancer, acute myeloid leukemia, and ovarian cancer (Han2015High; Han2019SOX30; Zhou2018Identification).

## Structure
The SOX30 protein is a member of the SOX family of transcription factors, characterized by the presence of a High Mobility Group (HMG) domain. This domain is crucial for DNA binding and is highly conserved across species, showing at least 50% identity with the HMG domain of the SRY gene (Bullejos2000HMGboxsequencesfrommicrobatshomologoustothehumanSOX30HMGbox). The HMG-box domain typically forms an L-shaped structure that interacts with the minor groove of DNA, facilitating transcriptional regulation.

In terms of primary structure, the SOX30 protein in various species, such as the common carp, consists of 389 amino acids, including the HMG-box domain (Cao2020Molecular). The protein can exist in different isoforms due to alternative splicing, which may result in truncated proteins lacking the HMG-box domain and nuclear localization signal, potentially altering their transcriptional activation capacities (Han2010Characterization).

Post-translational modifications, such as phosphorylation, may influence the activity and stability of SOX30, although specific modifications for the human protein are not detailed in the provided context. The presence of splice variant isoforms suggests functional diversity, with some isoforms potentially acting as non-functional factors or dominant negative mutants (Han2010Characterization).

## Function
SOX30 is a transcription factor that plays a significant role in regulating gene expression during spermatogenesis, particularly in the later stages of meiosis and spermiogenesis. It is expressed in germ cells of both fetal ovaries and postnatal testes, with a higher expression in adult testes. SOX30 is crucial for male fertility, as its deletion in mice results in male infertility, although females remain fertile (Feng2017SOX30).

In the testes, SOX30 is involved in the transcriptional regulation of haploid genes, which are essential for the development of spermatids. It initiates the transcription of these genes during late meiosis and spermiogenesis, ensuring the proper progression of spermatogenic cells into later stages such as diakinesis and metaphase (Bai2018Sox30). SOX30's function is intrinsic to testicular germ cells, where it regulates the expression of several key genes involved in spermiogenesis, either directly or indirectly (Feng2017SOX30).

SOX30 is active in the nucleus, where it binds to DNA to modulate the transcription of target genes. This activity is crucial for the molecular processes underlying male fertility, highlighting its importance in the differentiation and development of germ cells (Feng2017SOX30).

## Clinical Significance
SOX30 has been implicated in various diseases due to alterations in its expression and methylation. In non-small cell lung cancer (NSCLC), particularly lung adenocarcinoma (ADC), high SOX30 expression is associated with favorable survival outcomes and acts as an independent prognostic factor. It functions as a tumor suppressor by promoting apoptosis and inhibiting proliferation through p53 transcription regulation. However, this prognostic significance is not observed in squamous cell carcinoma (SCC) (Han2015High).

In acute myeloid leukemia (AML), SOX30 is frequently hypermethylated, leading to its downregulation. This hypermethylation is associated with poorer prognosis, lower complete remission rates, and shorter overall survival. SOX30 methylation serves as an independent adverse prognostic biomarker in AML (Zhou2018Identification).

In ovarian cancer, high SOX30 expression correlates with better overall survival in advanced-stage patients, suggesting its potential as a prognostic biomarker and chemotherapeutic indicator (Han2019SOX30).

SOX30 is also linked to male infertility, specifically non-obstructive azoospermia (NOA), where it is hypermethylated and silenced, leading to impaired spermatogenesis (Han2020Epigenetic).

## Interactions
SOX30 is a transcription factor that interacts with both proteins and nucleic acids to regulate gene expression. In lung cancer, SOX30 acts as a tumor suppressor by directly binding to the promoter region of the p53 gene, enhancing its transcription. This interaction leads to increased expression of p53 and its downstream targets, such as BAX, PMAIP1, and p21, which are involved in apoptotic pathways (Han2014SOX30). SOX30's role in promoting apoptosis and inhibiting proliferation in lung cancer cells is dependent on its interaction with p53, as blocking p53 activity diminishes these effects (Han2014SOX30).

In lung adenocarcinoma, SOX30 regulates desmosomal genes, including DSP, JUP, and DSC3, by binding to their promoter regions. This interaction suppresses tumor growth and metastasis by impairing the Wnt/β-catenin and ERK signaling pathways, which are inhibited by the upregulation of DSP and JUP (Hao2018SOX30). These interactions highlight SOX30's role in modulating key signaling pathways involved in cancer progression through its binding to specific DNA motifs and regulation of gene expression.


## References


[1. (Han2010Characterization) Fei Han, Zhijian Wang, Fengrui Wu, Zhihao Liu, Baofeng Huang, and Deshou Wang. Characterization, phylogeny, alternative splicing and expression of sox30 gene. BMC Molecular Biology, December 2010. URL: http://dx.doi.org/10.1186/1471-2199-11-98, doi:10.1186/1471-2199-11-98. This article has 48 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-2199-11-98)

[2. (Cao2020Molecular) Xianglin Cao, Xiaozhe Fu, Yidi Zhao, Baohua Li, Huajie Zhang, Nana Liu, Ninggiu Li, and Jianjun Chen. Molecular characterization and expression of the related-male gene sox30 in the common carp cyprinus carpio. Israeli Journal of Aquaculture - Bamidgeh, October 2020. URL: http://dx.doi.org/10.46989/001c.21467, doi:10.46989/001c.21467. This article has 0 citations.](https://doi.org/10.46989/001c.21467)

[3. (Feng2017SOX30) Chun-Wei Allen Feng, Cassy Spiller, Donna J. Merriner, Moira K. O’Bryan, Josephine Bowles, and Peter Koopman. Sox30 is required for male fertility in mice. Scientific Reports, December 2017. URL: http://dx.doi.org/10.1038/s41598-017-17854-5, doi:10.1038/s41598-017-17854-5. This article has 47 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-017-17854-5)

[4. (Han2020Epigenetic) Fei Han, Xiao Jiang, Zhi-ming Li, Xuan Zhuang, Xi Zhang, Wei-ming Ouyang, Wen-bin Liu, Cheng-yi Mao, Qing Chen, Chuan-shu Huang, Fei Gao, Zhi-hong Cui, Lin Ao, Yan-feng Li, Jia Cao, and Jin-yi Liu. Epigenetic inactivation of sox30 is associated with male infertility and offers a therapy target for non-obstructive azoospermia. Molecular Therapy - Nucleic Acids, 19:72–83, March 2020. URL: http://dx.doi.org/10.1016/j.omtn.2019.10.038, doi:10.1016/j.omtn.2019.10.038. This article has 23 citations.](https://doi.org/10.1016/j.omtn.2019.10.038)

[5. (Hao2018SOX30) Xianglin Hao, Fei Han, Bangjin Ma, Ning Zhang, Hongqiang Chen, Xiao Jiang, Li Yin, Wenbin Liu, Lin Ao, Jia Cao, and Jinyi Liu. Sox30 is a key regulator of desmosomal gene suppressing tumor growth and metastasis in lung adenocarcinoma. Journal of Experimental &amp; Clinical Cancer Research, May 2018. URL: http://dx.doi.org/10.1186/s13046-018-0778-3, doi:10.1186/s13046-018-0778-3. This article has 20 citations.](https://doi.org/10.1186/s13046-018-0778-3)

[6. (Han2015High) Fei Han, Wenbin Liu, Hualiang Xiao, Yan Dong, Lei Sun, Chengyi Mao, Li Yin, Xiao Jiang, Lin Ao, Zhihong Cui, Jia Cao, and Jinyi Liu. High expression of sox30 is associated with favorable survival in human lung adenocarcinoma. Scientific Reports, September 2015. URL: http://dx.doi.org/10.1038/srep13630, doi:10.1038/srep13630. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep13630)

[7. (Han2014SOX30) F Han, W Liu, X Jiang, X Shi, L Yin, L Ao, Z Cui, Y Li, C Huang, J Cao, and J Liu. Sox30, a novel epigenetic silenced tumor suppressor, promotes tumor cell apoptosis by transcriptional activating p53 in lung cancer. Oncogene, 34(33):4391–4402, December 2014. URL: http://dx.doi.org/10.1038/onc.2014.370, doi:10.1038/onc.2014.370. This article has 54 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/onc.2014.370)

[8. (Bai2018Sox30) Shun Bai, Kaiqiang Fu, Huiqi Yin, Yiqiang Cui, Qiuling Yue, Wenbo Li, Le Cheng, Huanhuan Tan, Xiaofei Liu, Yueshuai Guo, Yingwen Zhang, Jie Xie, Wenxiu He, Yuanyuan Wang, Hua Feng, Changpeng Xin, Jinwen Zhang, Mingyan Lin, Bin Shen, Zheng Sun, Xuejiang Guo, Ke Zheng, and Lan Ye. Sox30 initiates transcription of haploid genes during late meiosis and spermiogenesis in mouse testes. Development, January 2018. URL: http://dx.doi.org/10.1242/dev.164855, doi:10.1242/dev.164855. This article has 36 citations and is from a peer-reviewed journal.](https://doi.org/10.1242/dev.164855)

[9. (Zhou2018Identification) Jing-dong Zhou, Yu-xin Wang, Ting-juan Zhang, Xi-xi Li, Yu Gu, Wei Zhang, Ji-chun Ma, Jiang Lin, and Jun Qian. Identification and validation of sry-box containing gene family member sox30 methylation as a prognostic and predictive biomarker in myeloid malignancies. Clinical Epigenetics, July 2018. URL: http://dx.doi.org/10.1186/s13148-018-0523-y, doi:10.1186/s13148-018-0523-y. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13148-018-0523-y)

[10. (Bullejos2000HMGboxsequencesfrommicrobatshomologoustothehumanSOX30HMGbox) Mónica Bullejos, Rafael Díaz de la Guardia, María José L. Barragán, and Antonio Sánchez. Hmg-box sequences from microbats homologous to the human sox30 hmg-box. Genetica, 110(2):157–162, 2000. URL: http://dx.doi.org/10.1023/A:1017914005677, doi:10.1023/a:1017914005677. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1023/A:1017914005677)

[11. (Han2019SOX30) Fei Han, Wen-bin Liu, Jian-jun Li, Ming-qian Zhang, Jun-tang Yang, Xi Zhang, Xiang-lin Hao, Li Yin, Cheng-yi Mao, Xiao Jiang, Jia Cao, and Jin-yi Liu. Sox30 is a prognostic biomarker and chemotherapeutic indicator for advanced-stage ovarian cancer. Endocrine-Related Cancer, 26(3):303–319, March 2019. URL: http://dx.doi.org/10.1530/erc-18-0529, doi:10.1530/erc-18-0529. This article has 10 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1530/erc-18-0529)